Unichem Laboratories receives ANDA approval for Apremilast Tablets
Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis .
Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis .
It is used to treat low blood pressure that causes severe dizziness or a lightheaded feeling.
Droxidopa Capsules, 100 mg, 200 mg, and 300 mg, are indicated for the treatment of orthostatic dizziness
Dr. Reddy's will present the safety profile of the phase 2 study, and interim data of the phase 3 study, which is expected to complete by 2pt February 2021.
The company had started replacement of one of the main equipments in the said plant which is expected to take further 30 to 40 days to complete the installation and resume production.
The company launched initiatives to move forward towards this goal In 2020.
Proceeds from the ransaction will improve Superior’s financial flexibility and allow the company to accelerate its growth through acquisitions of retail propane distribution businesses.
Fluphenazine Hydrochloride Tablets, USP are available in 1 mg, 2.5 mg, 5 mg, and 10 mg tablets in 100 bottle count sizes.
The new building after installation of plant and machinery is now in operation after the trial runs.
Company will invest some EUR 10 million in the new glass-fiber sheet molding compound (GF-SMC) line, which will begin operating in autumn 2022 to help meet strong demand for Teijin’s composite formulations in Europe
The dividend cheque was presented by Shriniwas C. Mudgerikar, CMD of RCF in presence of R K Chaturvedi, Secretary (Fertilisers) and other senior officers of Department of Fertilisers.
PCBL is India’s largest carbon black manufacturer having 4 plants at strategic locations in India.
Granules now has a total of 37 ANDA approvals from US FDA (36 Final approvals and 1 tentative approvals).
posaconazole delayed-release tablets 100 mg are the generic equivalent of Noxafil.
EBITDA excluding non-recurring items amounted to SEK 257 m (275).
Revenue of $783 million increased 13 percent compared to $693 million.
Decreased custom duty on naphtha is likely to further improve the utilization of crackers resulting in availability of cost competitive olefins and aromatics.
Responding to a media report ‘Clariant Chemicals to buy 51% in India Glycols' specialty chemical biz’, India Glycols stated that the company is yet to take any final decision regarding any collaboration.
The Profit before exceptional item & tax stood at Rs. 19.0 crore for the quarter ended December 31, 2020.
Net debt for the total Group decreased to CHF 1.040 billion versus CHF 1.372 billion recorded at the end of 2019.
Subscribe To Our Newsletter & Stay Updated